Anti‐asialo‐GM1 inhibits vaccinia virus infection of murine ovaries: Asialo‐GM1 as an additional virus receptor?
- 1 October 1990
- journal article
- research article
- Published by Wiley in Immunology & Cell Biology
- Vol. 68 (5) , 343-346
- https://doi.org/10.1038/icb.1990.46
Abstract
Summary: The neurovirulent strain of vaccinia virus, VV‐WR, or recombinants derived from VV‐WR, cause highly productive infection of murine ovaries, but infection could be partially inhibited in vivo using an antiserum to asialo‐GM1 (as‐GM1). In vitro analysis by flow cytometry revealed that murine ovarian cells expressed a cell surface antigen identical to or cross‐reactive with as‐GM1. The capacity of VV‐WR to infect murine ovaries appears to depend in part upon as‐GM1expression on ovarian cells.This publication has 9 references indexed in Scilit:
- Vaccinia virus‐mediated damage of murine ovaries and protection by virus‐expressed interleukin‐2Immunology & Cell Biology, 1990
- Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2.The Journal of Immunology, 1990
- Cell proliferative response to vaccinia virus is mediated by VGFVirology, 1988
- Inhibition of rabies virus infection by a soluble membrane fraction from the rat central nervous systemArchiv für die gesamte Virusforschung, 1988
- Epidermal growth factor receptor occupancy inhibits vaccinia virus infectionNature, 1985
- Purification and characterization of vaccinia virus growth factorCell, 1985
- Establishment of Monoclonal Anti-Nk-1.1 AntibodyHybridoma, 1984
- A glycolipid on the surface of mouse natural killer cellsEuropean Journal of Immunology, 1980
- Non‐producer human cells induced by murine sarcoma virusInternational Journal of Cancer, 1975